Changes in Hematological, Clinical and Laboratory Parameters for Children with COVID-19: Single-Center Experience

References

• Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi:10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Worldometers. COVID-19 coronavirus pandemic; 2021 [cited July 3, 2021]. Available from: https://www.worldometers.info/coronavirus/?utm_campaign=homeAdvegas1?. Accessed August 18, 2021.
   Google Scholar
• Becker RC. COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis. 2020;50(1):54–67. doi:10.1007/s11239-020-02134-3
   PubMed Web of Science ®Google Scholar
• Grewal S, Harjo B, Aykut G, et al. Case report: sublingual microcirculatory alterations in a Covid-19 patient with subcutaneous emphysema, venous thrombosis, and pneumomediastinum. Front Med. 2020;7:624695. doi:10.3389/fmed.2020.624695
   Web of Science ®Google Scholar
• Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098.
   PubMed Web of Science ®Google Scholar
• Iba T, Levy JH, Levi M, Connors JM, Thachil J. Coagulopathy of coronavirus disease 2019. Crit Care Med. 2020;48(9):1358–1364. doi:10.1097/CCM.0000000000004458
   PubMed Web of Science ®Google Scholar
• Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. doi:10.1111/jth.14768
   PubMed Web of Science ®Google Scholar
• Yao Y, Cao J, Wang Q, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care. 2020;8(1):1–11. doi:10.1186/s40560-020-00466-z
   PubMed Web of Science ®Google Scholar
• Zhang L, Yan X, Fan Q, et al. D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19. J Thromb Haemost. 2020;18(6):1324–1329. doi:10.1111/jth.14859
   PubMed Web of Science ®Google Scholar
• Eljilany I, Elzouki A-N. D-dimer, fibrinogen, and IL-6 in COVID-19 patients with suspected venous thromboembolism: a narrative review. Vasc Health Risk Manag. 2020;16:455. doi:10.2147/VHRM.S280962
   PubMed Web of Science ®Google Scholar
• Cushman M, editor. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44(2):62–69. Elsevier.
   PubMed Web of Science ®Google Scholar
• Celkan T, Dikme G. Thrombosis in children: which test to whom, when and how much necessary? Turk Arch Pediatr. 2018;53(1):1. doi:10.5152/TurkPediatriArs.2018.2586
   Web of Science ®Google Scholar
• Goldenberg NA, Sochet A, Albisetti M, et al. Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19–related illness. J Thromb Haemost. 2020;18(11):3099–3105. doi:10.1111/jth.15073
   PubMed Web of Science ®Google Scholar
• Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in US children and adolescents. N Engl J Med. 2020;383(4):334–346. doi:10.1056/NEJMoa2021680
   PubMed Web of Science ®Google Scholar
• Loi M, Branchford B, Kim J, Self C, Nuss R. COVID‐19 anticoagulation recommendations in children. Pediatr Blood Cancer. 2020;67(9):e28485. doi:10.1002/pbc.28485
   Web of Science ®Google Scholar
• Thachil J, Cushman M, Srivastava A. A proposal for staging COVID-19 coagulopathy. Res Pract Thromb Haemost. 2020;4(5):731–736. doi:10.1002/rth2.12372
   PubMed Web of Science ®Google Scholar
• Fan L, Liu S. CT and COVID-19: Chinese experience and recommendations concerning detection, staging and follow-up. Eur Radiol. 2020;30(9):5214–5216.
   Web of Science ®Google Scholar
• Marchandot B, Trimaille A, Curtiaud A, et al. Staging severity of COVID-19 according to hemostatic abnormalities (CAHA score). Thromb Haemost. 2020;120(12):1716–1719.
   Web of Science ®Google Scholar
• Cordon-Cardo C, Pujadas E, Wajnberg A, et al. COVID-19: staging of a new disease. Cancer Cell. 2020;38(5):594–597. doi:10.1016/j.ccell.2020.10.006
   PubMed Web of Science ®Google Scholar
• Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID‐19. J Thromb Haemost. 2020;18(5):1023–1026. doi:10.1111/jth.14810
   PubMed Web of Science ®Google Scholar
• Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID‐19. J Thromb Haemost. 2020;18(9):2103–2109. doi:10.1111/jth.14975
   PubMed Web of Science ®Google Scholar
• Caro-Dominguez P, Shelmerdine SC, Toso S, et al. Thoracic imaging of coronavirus disease 2019 (COVID-19) in children: a series of 91 cases. Pediatr Radiol. 2020;50(10):1354–1368. doi:10.1007/s00247-020-04747-5
   Web of Science ®Google Scholar
• Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6):e20200702. doi:10.1542/peds.2020-0702
   PubMed Web of Science ®Google Scholar
• Ogimi C, Englund JA, Bradford MC, Qin X, Boeckh M, Waghmare A. Characteristics and outcomes of coronavirus infection in children: the role of viral factors and an immunocompromised state. J Pediatric Infect Dis Soc. 2019;8(1):21–28. doi:10.1093/jpids/pix093
   PubMed Web of Science ®Google Scholar
• Del Borrello G, Giraudo I, Bondone C, et al. SARS-CoV-2 associated coagulopathy and thromboembolism prophylaxis in children: a Single Centre Observational Study. J Thromb Haemost. 2021;19(2):522–530.
   PubMed Web of Science ®Google Scholar
• Zou Y, Guo H, Zhang Y, et al. Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China. Biosci Trends. 2020;14(4):285–289. doi:10.5582/bst.2020.03086
   PubMed Web of Science ®Google Scholar
• Thachil J, Agarwal S. Understanding the COVID-19 coagulopathy spectrum. Anaesthesia. 2020;75(11):1432–1436. doi:10.1111/anae.15141
   PubMed Web of Science ®Google Scholar
• Zimmermann P, Curtis N. COVID-19 in children, pregnancy and neonates: a review of epidemiologic and clinical features. Pediatr Infect Dis J. 2020;39(6):469. doi:10.1097/INF.0000000000002700
   PubMed Web of Science ®Google Scholar
• Leung CW, Kwan YW, Ko PW, et al. Severe acute respiratory syndrome among children. Pediatrics. 2004;113(6):e535–e543. doi:10.1542/peds.113.6.e535
   Web of Science ®Google Scholar
• Al-Tawfiq JA, Kattan RF, Memish ZA. Middle east respiratory syndrome coronavirus disease is rare in children: an update from Saudi Arabia. World J Clin Pediatr. 2016;5(4):391. doi:10.5409/wjcp.v5.i4.391
   Google Scholar
• Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5(4):562–569. doi:10.1038/s41564-020-0688-y
   PubMed Web of Science ®Google Scholar
• Patel AB, Verma A. COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? JAMA. 2020;323(18):1769–1770.
   PubMed Web of Science ®Google Scholar
• Patel AB, Verma A. Nasal ACE2 levels and COVID-19 in children. JAMA. 2020;323(23):2386–2387. doi:10.1001/jama.2020.8946
   Web of Science ®Google Scholar
• Rivas-Ruiz R, Roy-García IA, Ureña-Wong KR, et al. Factors associated with death in children with COVID-19 in Mexico. Gac Med Mex. 2020;156(6):516–522.
   PubMedGoogle Scholar
• Yaylacı S, Dheir H, Işsever K, et al. The effect of abo and rh blood group antigens on admission to intensive care unit and mortality in patients with COVID-19 infection. Rev Assoc Med Bras. 2020;66(suppl 2):86–90. doi:10.1590/1806-9282.66.s2.86
   Web of Science ®Google Scholar